What's New
Last Posted: May 31, 2019
- Genetic Testing After a Terminal Diagnosis—Providing Purpose
J Solimine, JAMA Oncology, May 30, 2019 - Grail, a deep-pocketed startup, shows ‘impressive,’ if early, results for cancer blood test
M Herper, Stat News, May 31, 2019 - New Drugs, New Side Effects: Complications of Cancer Immunotherapy
NCI, May 2019 - Next Generation Sequencing—Testing Multiple Genetic Markers at Once
MD Ewalt et al, JAMA Oncology, May 30, 2019 - Tumor Mutation Burden—From Hopes to Doubts
A Addeo et al, JAMA Oncology, May 30, 2019 - Genetic Variation in LPA, Calcific Aortic Valve Stenosis in Patients Undergoing Cardiac Surgery, and Familial Risk of Aortic Valve Microcalcification.
Perrot Nicolas et al. JAMA cardiology 2019 May - Assessment of tumor mutation burden calculation from gene panel sequencing data.
Xu Zhenwu et al. OncoTargets and therapy 2019 123401-3409 - Avoiding over- and undertreatment in patients with resected node-positive breast cancer with the use of gene expression signatures: are we there yet?
Matikas A et al. Annals of oncology : official journal of the European Society for Medical Oncology 2019 Apr - Clinical utility of custom-designed NGS panel testing in pediatric tumors.
Surrey Lea F et al. Genome medicine 2019 May 11(1) 32 - Cost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancer.
Hannouf Malek B et al. The pharmacogenomics journal 2019 May - Evaluating gene fusions in solid tumors - Clinical experience using an RNA based 53 gene next-generation sequencing panel.
Selvam Pavalan et al. Cancer genetics 2019 Apr 233-23432-42 - Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer.
Kemp Zoe et al. JAMA network open 2019 May 2(5) e194428 - Gene Expression Profiling for Diagnosis of Triple-Negative Breast Cancer: A Multicenter, Retrospective Cohort Study.
Wang Qifeng et al. Frontiers in oncology 2019 9354 - Genetic polymorphisms of vascular endothelial growth factor (VEGF) associated with gastric cancer recurrence after curative resection with adjuvant chemotherapy.
Kim Yeon-Ji et al. BMC cancer 2019 May 19(1) 483 - Identification of Hub Genes Associated With Progression and Prognosis in Patients With Bladder Cancer.
Yan Xin et al. Frontiers in genetics 2019 10408
No hay comentarios:
Publicar un comentario